<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutation of PIK3CA, the gene coding for the p110alpha catalytic subunit of <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> 3-kinase (PI3K), has been reported in a limited range of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We now report that PIK3CA is also mutated in <z:e sem="disease" ids="C0014859" disease_type="Neoplastic Process" abbrv="">esophageal tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Single-strand conformational polymorphism (SSCP) and denaturing high-performance liquid chromatography (DHPLC) were used to screen <z:hpo ids='HP_0000001'>all</z:hpo> 20 exons of PIK3CA in 101 samples from 95 individuals with <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> and/or <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0001428'>Somatic mutation</z:hpo> of PIK3CA was detected in 4 of 35 (11.8%) of esophageal <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) and 3 of 50 (6%) <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>No mutations were detected in any of 17 samples of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>For PIK3CB, we screened exons 11 and 22, which code for the regions corresponding to the exon 9 and 20 mutational 'hotspots' of PIK3CA </plain></SENT>
<SENT sid="6" pm="."><plain>No somatic changes were detected in PIK3CB This study extends previous observations in other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> types by demonstrating the presence of somatic PIK3CA mutations in both <z:mp ids='MP_0004207'>SCC</z:mp> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, thus implicating the PI3K pathway in the initiation and/or progression of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> </plain></SENT>
</text></document>